Drazba Brian G. 4

4 · MEI Pharma, Inc. · Filed Jul 6, 2021

Form 4

Period: 2021-07-01

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2021-07-01+200,000→ 200,000 total
Exercise: $2.95Exp: 2031-07-01→ Common Stock (200,000 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $4.33Exp: 2028-06-22→ Common Stock (130,000 underlying)
130,000
Stock Option (Right to Buy)
Exercise: $4.28Exp: 2028-07-12→ Common Stock (100,000 underlying)
100,000
Stock Option (Right to Buy)
Exercise: $2.52Exp: 2029-07-01→ Common Stock (230,000 underlying)
230,000
Stock Option (Right to Buy)
Exercise: $1.59Exp: 2027-04-03→ Common Stock (150,000 underlying)
150,000
Stock Option (Right to Buy)
Exercise: $2.83Exp: 2027-07-06→ Common Stock (50,000 underlying)
50,000
Stock Option (Right to Buy)
Exercise: $3.49Exp: 2030-07-02→ Common Stock (230,000 underlying)
230,000

Footnotes (7)

[F1]One-quarter of such options shall vest on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
[F2]All of such options are presently exercisable.
[F3]One-quarter of such options vested on July 6, 2018 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 6, 2018.
[F4]One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
[F5]One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
[F6]One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
[F7]One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.

Documents

1 file